Skin pigmentation disease
Conditions
Interventions
Product from this study (three sunscreens), to select one or more, depending on the UV shielding effect of the treatment sought.
Sponsors
Department of Plastic and Reconstructive Surgery, University of Tsukuba
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: attribute Patients with skin pigmentation, skin graft patient, patient suture
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| At the first visit (before start of the application), and the observation and measurement of the following (after 8 weeks) after 4 weeks and at the end. skin findings Observe the treatment site, fill in the card case is determined at step 5 the state of erythema and eschar. photography Taken by a digital camera the treatment site. skin color Measured by (CM-2600d Konica Minolta) spectral colorimeter skin color or skin graft or suture site site (healthy) and its marginal treatment site. Collected stratum corneum by tape stripping Collecting the outermost layer of the stratum corneum site (healthy) and marginal treatment site by:Sellotape (only at the beginning and end) QOL survey The investigation by Skindex-16 is a measure of the subject-specific QOL skin. | — |
Countries
Japan
Contacts
Public ContactKoji Adachi
University of Tsukuba Department of Plastic and Reconstructive Surgery
Outcome results
None listed